UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Madison Square Garden
MSGE
$3.81B
| $4.1M | ﹤0.01% |
102,683
+70,337
| +217% | +$2.48M |
2023 Q3
7 quarters
|
|
1802
Universal Corp
UVV
$1.05B
| $4.1M | ﹤0.01% |
70,381
+33,423
| +90% | +$1.92M |
2013 Q2
48 quarters
|
|
1803
Aurora
AUR
$11.4B
| $4.09M | ﹤0.01% |
781,253
-1,265,507
| -62% | -$7.94M |
2023 Q1
9 quarters
|
|
1804
Equinox Gold
EQX
$13.2B
| $4.08M | ﹤0.01% |
709,692
-70,449
| -9% | -$458K |
2024 Q2
4 quarters
|
|
1805
Icon
ICLR
$13B
| $4.08M | ﹤0.01% |
28,054
+3,347
| +14% | +$475K |
2020 Q2
20 quarters
|
|
1806
Praxis Precision Medicines
PRAX
$7.09B
| $4.08M | ﹤0.01% |
96,945
+9,864
| +11% | +$376K |
2024 Q2
4 quarters
|
|
1807
German American Bancorp
GABC
$1.83B
| $4.06M | ﹤0.01% |
105,503
+50,133
| +91% | +$1.88M |
2019 Q3
23 quarters
|
|
1808
Protolabs
PRLB
$2.21B
| $4.06M | ﹤0.01% |
101,431
+22,240
| +28% | +$829K |
2013 Q2
48 quarters
|
|
1809
Middlesex Water
MSEX
$1B
| $4.05M | ﹤0.01% |
74,779
+15,557
| +26% | +$921K |
2014 Q1
45 quarters
|
|
1810
Bio-Rad Laboratories Class A
BIO
$9.75B
| $4.04M | ﹤0.01% |
16,749
-366,058
| -96% | -$86.5M |
2013 Q2
48 quarters
|
|
1811
Westamerica Bancorp
WABC
$1.37B
| $4.04M | ﹤0.01% |
83,365
+19,314
| +30% | +$925K |
2013 Q2
48 quarters
|
|
1812
Bowhead Specialty Holdings
BOW
$1.12B
| $4.03M | ﹤0.01% |
107,285
-10,082
| -9% | -$386K |
2024 Q2
4 quarters
|
|
1813
REX American Resources
REX
$1.4B
| $4.02M | ﹤0.01% |
164,924
+436
| +0.3% | +$9.2K |
2020 Q4
18 quarters
|
|
1814
Cannae Holdings
CNNE
$675M
| $4.01M | ﹤0.01% |
192,539
+20,472
| +12% | +$378K |
2017 Q4
30 quarters
|
|
1815
Tenaris
TS
$29.3B
| $3.98M | ﹤0.01% |
106,460
-33,094
| -24% | -$1.13M |
2025 Q1
1 quarter
|
|
1816
Sally Beauty Holdings
SBH
$1.48B
| $3.97M | ﹤0.01% |
428,658
+103,752
| +32% | +$894K |
2013 Q2
48 quarters
|
|
1817
Xometry
XMTR
$6.27B
| $3.97M | ﹤0.01% |
117,378
+51,029
| +77% | +$1.5M |
2023 Q3
7 quarters
|
|
1818
Crescent Energy
CRGY
$4.28B
| $3.97M | ﹤0.01% |
461,075
+216,619
| +89% | +$1.9M |
2022 Q2
12 quarters
|
|
1819
NextNav
NN
$1.98B
| $3.96M | ﹤0.01% |
260,696
+125,818
| +93% | +$1.61M |
2023 Q4
6 quarters
|
|
1820
Astrana Health
ASTH
$1.88B
| $3.94M | ﹤0.01% |
158,439
+54,333
| +52% | +$1.53M |
2019 Q4
22 quarters
|
|
1821
Encore Capital Group
ECPG
$2.12B
| $3.93M | ﹤0.01% |
101,605
+23,140
| +29% | +$839K |
2017 Q1
33 quarters
|
|
1822
BrightView Holdings
BV
$982M
| $3.93M | ﹤0.01% |
235,784
+64,710
| +38% | +$968K |
2019 Q2
24 quarters
|
|
1823
Array Technologies
ARRY
$548M
| $3.92M | ﹤0.01% |
663,690
+111,715
| +20% | +$678K |
2021 Q1
17 quarters
|
|
1824
Astec Industries
ASTE
$899M
| $3.9M | ﹤0.01% |
93,484
+27,907
| +43% | +$1.06M |
2023 Q1
9 quarters
|
|
1825
Sprout Social
SPT
$671M
| $3.87M | ﹤0.01% |
184,899
+58,764
| +47% | +$1.25M |
2020 Q3
19 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.